X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (348) 348
Patent (176) 176
Conference Proceeding (21) 21
Book / eBook (4) 4
Publication (4) 4
Book Chapter (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
physics (79) 79
chemistry (76) 76
metallurgy (72) 72
humans (68) 68
performing operations (64) 64
transporting (64) 64
electricity (59) 59
female (53) 53
male (53) 53
index medicus (52) 52
aged (48) 48
compositions based thereon (47) 47
organic macromolecular compounds (47) 47
their preparation or chemical working-up (47) 47
cardiovascular (46) 46
cardiac & cardiovascular systems (44) 44
middle aged (43) 43
basic electric elements (40) 40
heart failure (36) 36
measuring (32) 32
testing (32) 32
internal medicine (29) 29
prognosis (29) 29
organic chemistry (28) 28
risk factors (27) 27
care and treatment (26) 26
macromolecular compounds obtained otherwise than by reactionsonly involving unsaturated carbon-to-carbon bonds (26) 26
optics (22) 22
vehicles in general (22) 22
cardiology (20) 20
general tagging of cross-sectional technologies spanning over several sections of the ipc (20) 20
general tagging of new technological developments (20) 20
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (20) 20
correction of typographical errors (19) 19
heart attacks (19) 19
human necessities (19) 19
i.e. mechanisms printing otherwise than from a forme (19) 19
lining machines (19) 19
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (19) 19
printing (19) 19
selective printing mechanisms (19) 19
stamps (19) 19
typewriters (19) 19
dyes (18) 18
aged, 80 and over (17) 17
calculating (17) 17
computing (17) 17
counting (17) 17
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (17) 17
electric communication technique (17) 17
electric solid state devices not otherwise provided for (17) 17
frequency-changing (17) 17
heart attack (17) 17
mortality (17) 17
non-linear optics (17) 17
optical analogue/digital converters (17) 17
optical logic elements (17) 17
prospective studies (17) 17
semiconductor devices (17) 17
techniques or procedures for the operation thereof (17) 17
technologies or applications for mitigation or adaptation againstclimate change (17) 17
adhesives (16) 16
analysis (16) 16
cables (16) 16
conductors (16) 16
diagnosis (16) 16
insulators (16) 16
miscellaneous applications of materials (16) 16
miscellaneous compositions (16) 16
natural resins (16) 16
paints (16) 16
polishes (16) 16
selection of materials for their conductive, insulating ordielectric properties (16) 16
conjoint control of vehicle sub-units of different type ordifferent function (15) 15
control systems specially adapted for hybrid vehicles (15) 15
materials for miscellaneous applications, not provided forelsewhere (15) 15
pictorial communication, e.g. television (15) 15
road vehicle drive control systems for purposes not related tothe control of a particular sub-unit (15) 15
atherosclerosis (14) 14
cardiac patients (14) 14
electrocardiography (14) 14
polymer science (14) 14
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (14) 14
acute coronary syndrome (13) 13
after-treatment not covered by subclasses c08b, c08c, c08f,c08g (13) 13
cardiovascular disease (13) 13
general processes of compounding (13) 13
hygiene (13) 13
medical or veterinary science (13) 13
working-up (13) 13
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (12) 12
climate change mitigation technologies in the production orprocessing of goods (12) 12
coronary heart disease (12) 12
diabetes (12) 12
endothelium (12) 12
follow-up studies (12) 12
heterocyclic compounds (12) 12
land vehicles for travelling otherwise than on rails (12) 12
motor vehicles (12) 12
oncology (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1975, 183 p., [3] leaves of plates
Book
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 3, pp. 265 - 276
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2017, Volume 69, Issue 25, pp. 3042 - 3051
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 60, Issue 18, pp. 1778 - 1786
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2011, Volume 57, Issue 7, pp. 861 - 869
Journal Article
Circulation Journal, ISSN 1346-9843, 2013, Volume 77, Issue 5, pp. 1337 - 1344
Background: Dipeptidyl peptidase 4 (DPP4) inhibitors are used for treatment of diabetes mellitus (DM). We hypothesized that sitagliptin, a DPP4-inhibitor,... 
Dipeptidyl peptidase-4 inhibitors | Inflammation | Endothelial function | PROGENITOR CELLS | CARDIAC & CARDIOVASCULAR SYSTEMS | NITRIC-OXIDE SYNTHASE | ATHEROSCLEROSIS | AMPLITUDE | MELLITUS | PATHOPHYSIOLOGY | HEART-DISEASE | GLUCAGON-LIKE PEPTIDE-1 | CARDIOVASCULAR RISK | Multivariate Analysis | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Endothelium, Vascular - drug effects | Male | Pyrazines - therapeutic use | Coronary Artery Disease - blood | Diabetic Angiopathies - physiopathology | C-Reactive Protein - metabolism | Coronary Artery Disease - physiopathology | Time Factors | Diabetes Mellitus, Type 2 - immunology | Peripheral Arterial Disease - blood | Anti-Inflammatory Agents - therapeutic use | Female | Sitagliptin Phosphate | Odds Ratio | Diabetes Mellitus, Type 2 - complications | Endothelium, Vascular - immunology | Triazoles - therapeutic use | Manometry | Risk Factors | Endothelium, Vascular - physiopathology | Inflammation Mediators - blood | Peripheral Arterial Disease - drug therapy | Linear Models | Logistic Models | Treatment Outcome | Biomarkers - blood | Coronary Artery Disease - drug therapy | Diabetic Angiopathies - blood | Diabetic Angiopathies - drug therapy | Chi-Square Distribution | Peripheral Arterial Disease - physiopathology | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Peripheral Arterial Disease - immunology | Diabetic Angiopathies - immunology | Aged | Coronary Artery Disease - immunology | Diabetes Mellitus, Type 2 - drug therapy
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 19, pp. 1964 - 1972
Journal Article
Composites Science and Technology, ISSN 0266-3538, 2010, Volume 70, Issue 10, pp. 1564 - 1570
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2012, Volume 59, Issue 3, pp. 265 - 276
The aim of this study was to investigate the antiatherogenic effects of the dipeptidyl peptidase-4 inhibitor, des-fluoro-sitagliptin (DFS). The new class of... 
atherosclerosis | dipeptidyl peptidase-4 inhibitors | endothelium | glucagon-like peptide 1 receptor | receptors | inflammation
Journal Article
Journal of Cardiac Failure, ISSN 1071-9164, 10/2017, Volume 23, Issue 10, p. S26
Journal Article
Journal Article